These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23817654)

  • 1. [Is it possible to handle genitourinary system infections in our area with empirical treatment, following recommendations from recent guidelines?].
    Viñuela L; de Frutos-Serna M; Asensio ML; Muñoz-Bellido JL; García-Sánchez JE
    Rev Esp Quimioter; 2013 Jun; 26(2):159-61. PubMed ID: 23817654
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of clinical guidelines.
    Postgrad Med; 2001 Aug; 110(2 Suppl):16-20; discussion 26-7. PubMed ID: 19667572
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 6. [The sensitivity of the uropathogenic Escherichia coli strains to antibiotics, bacteriophages and bactericidal serum activity].
    Drulis-Kawa Z; Weber-Dabrowska B; Lewczyk E; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2002 Dec; 13(78):470-2. PubMed ID: 12666443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
    Anderson K
    Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of quinolones against isolates from paediatric urinary tract infections from three Venezuelan centres.
    Rodríguez AJ; Rodríguez CN; Meijomil P; García A; Duque C; Molina N; Barbella R; Lakatos M; Bellorin E; Mendoza M
    Int J Antimicrob Agents; 2001 Jun; 17(6):531-2. PubMed ID: 11397626
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence and risk factors for fosfomycin resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection.
    Ramos J; Bastida MT; Niño E; Smithson A
    Enferm Infecc Microbiol Clin (Engl Ed); 2019; 37(7):484-485. PubMed ID: 30075982
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
    BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrofurantoin: an effective and ignored antimicrobial.
    Arya SC; Agarwal N; Agarwal S
    Int J Antimicrob Agents; 2006 Apr; 27(4):354-5. PubMed ID: 16531014
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
    Karlowsky JA; Hoban DJ; Decorby MR; Laing NM; Zhanel GG
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2251-4. PubMed ID: 16723598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferable antibiotic resistance in Escherichia coli isolated from urinary-tract infections: hospital v. community patients.
    Rotimi VO; Emina PA; Eke PI
    Afr J Med Med Sci; 1984; 13(1-2):47-53. PubMed ID: 6087639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity data in support of nitrofurantoin three times per day.
    Amábile-Cuevas CF; Arredondo-García JL
    J Antimicrob Chemother; 2011 Jul; 66(7):1652-3. PubMed ID: 21525023
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatient departments in Germany.
    Kresken M; Körber-Irrgang B
    Antimicrob Agents Chemother; 2014 Nov; 58(11):7019-20. PubMed ID: 25182654
    [No Abstract]   [Full Text] [Related]  

  • 16. [The Uripret-system for the identification and sensitivity testing of the causative agents of urinary tract infections].
    Juretschke R; Kollias G; Rinsche KG
    MMW Munch Med Wochenschr; 1978 Jan; 120(4):111-2. PubMed ID: 342923
    [No Abstract]   [Full Text] [Related]  

  • 17. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.
    Le TP; Miller LG
    Clin Infect Dis; 2001 Sep; 33(5):615-21. PubMed ID: 11486284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France.
    Duployez C; Robert J; Vachée A;
    Med Mal Infect; 2018 Sep; 48(6):410-413. PubMed ID: 29673879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.